Tuesday, December 27, 2016

Ebola vaccine highly effective in final trial results

VSV-EBOV uses an Ebola protein spliced into a vesicular stomatitis virus (VSV); it was developed in Canada and licensed by NewLink Genetics and … Full Article http://j.gs/5sTq

Click here to read full article
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)